Selected references
- Ronnett BM, Kurman FJ, Zahn CM. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis of site of origin, prognosis and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 1995;26: 509 —524
- Sugarbaker P. Cytoreductive surgery and pen-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei. Eur J Surg Oncol 2001;27:239 — 243
- Witkamp AJ, de Bree E, Kaag MM, van Sloten GW, van Coevorden F, Zoetmulder F. Extensive surgical cytoreduc-tion and intraoperative hyperthermic intraperitonel chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001;88:458 — 463
Suggested reading
- Bechtold RE, Chen MYM, Loggie BW, Jackson SL, Geisinger K. CT appearance of disseminated peritoneal adenomuci-nosis. Abdom Imaging 2001;26:406 — 410
- McQuellon RP, Loggie BW, Lehman AB, Russel GB, Fleming RA, Shen P, et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hy-perthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 2003;10:155 — 162
- Shen P, Levine EA, Hall J, Case D, Russell G, Fleming R, et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin-C after cytoreductive surgery for patients with peritoneal carcino-matosis. Arch Surg 2003;138:26–33
- Van Ruth S, Hart AA, Bonfrer JM, Verwaal VJ, Zoetmulder FA. Prognostic value of baseline and serial carcino-embryonic antigen and carbohydrate antigen 19.9 meas-urements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2002;9: 961 —967